Human PBMC Isolation Kit Market Revenue to Attain USD 313.72 Mn by 2033

20 Jun 2025

Share :

Table of Content

1. Human PBMC Isolation Kit Market Revenue and Trends 2025 to 2033 2. 3. Overview of the Market 4. Segment Insights 5. Regional insights 6. Human PBMC Isolation Kit Market Coverage 7. Human PBMC Isolation Kit Market Key Players

Human PBMC Isolation Kit Market Revenue and Trends 2025 to 2033

The global human PBMC isolation kit market revenue surpass USD 162.86 million in 2025 and is predicted to attain around USD 313.72 million by 2033, growing at a CAGR of 8.54%. The market growth is attributed to the increasing research activities for studying cancer and infectious diseases. In addition, the rising demand for immunotherapy and increasing vaccine development contribute to market expansion.

Overview of the Market

The human PBMC isolation Kit market is expected to grow at a significant rate, driven by the increasing demand for personalized medicine and cell-based therapies. Rising research and development (R&D) activities in oncology also support market growth, as high-quality PBMCs (Peripheral Blood Mononuclear Cells) are essential for immunology and oncology research. Moreover, the study of infectious diseases and the impact of global pandemics will inevitably increase the need for dependable cell sources and isolation methods. Advances in biotechnology and the growing interest in regenerative medicine are also contributing to the market’s growth.

Segment Insights

• By product type, the density gradient medium segment held the largest share of the market in 2024. This is mainly due to its affordability, purity yield, and wide applications in immunology, virology, and translational research.
• By source, the whole blood segment led the market for human PBMC isolation kit since it is easily obtainable and rich in PBMCs. PBMCs derived from whole blood find applications in vaccine development and study disease pathogenesis.
• By application, the clinical research segment held the largest share of the market in 2024 due to the increase in demand for immunotherapy, and significant rise in the number of vaccine trials, and the development of personalized medicine that calls for precise immune cell profiling and detailed immune cell analysis.
• By end-user, the academic & research institutes segment led the market with a major share in 2024. This is mainly due to a rise in immunological research, government funding and grants for research, and a growing focus on immunology and cell-based studies in academic and research laboratories.
• By technology, the density gradient centrifugation segment contributed the largest share of the market in 2024. This is mainly due to its high effectiveness in separating biological molecules and high levels of cell viability.

Regional insights

North America registered dominance in the human PBMC isolation kit market by capturing the largest share in 2024. This is mainly due to its robust biotech infrastructure, increased government funding for cell-based research, and the presence of several key players in the U.S. and Canada. There is a high demand for cell therapies and personalized medicine, bolstering the market growth.

Asia‑Pacific is growing at the fastest rate due to the growing prevalence of infectious disease and the rising development of regenerative medicine. China, Japan, and India are leading the charge due to the increasing investments in biotech and the rising number of clinical trials and research activities.

Human PBMC Isolation Kit Market Coverage

Recent Development

• In May 2023, Akadeum Life Sciences launched a new series of products for cell therapy R&D, enabling direct leukopak human immune cell isolation and T-cell activation/expansion kits at the American Society of Gene + Cell Therapy's 26th Annual Meeting in Los Angeles, California. The new products expand Akadeum's lineup of Buoyancy-Activated Cell Sorting (BACS) Microbubble buoyancy-based cell isolation kits, enabling the direct isolation of T cells (leveraging GMP-grade kit reagents) and peripheral blood mononuclear cells (PBMCs) from leukapheresis material without the need for lysis or density gradient centrifugation.
  (Source: https://www.prnewswire.com)

Human PBMC Isolation Kit Market Key Players

• Abcam
• Amsbio
• BioVision
• Miltenyi Biotec
• Stemcell Technologies
• Thermo Fisher Scientific
• Fabgennix International Inc
• Zen-Bio

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6258

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344